Not surprisingly, established players continue to invest in 3D-printing research, while newer manufacturers are also breaking into the pharmaceutical space. An article by Jerry Martin.
Read More
Pharma production is ‘too conservative’ and needs to ‘be bolder’ in adopting nascent technologies, or be left behind by new models, suggested one MD. An article from Ben Hargreaves
Read More